Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride helps hair growth but stopping it causes faster hair loss.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss in women often starts in their late 20s and peaks after 50, and it's different from male hair loss.

DHT, a testosterone byproduct, causes male pattern baldness.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

No cure for female pattern hair loss, but various effective treatments exist.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Treat pattern hair loss with finasteride and topical minoxidil.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Hormones significantly affect hair growth and loss, requiring personalized treatment.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.